Paracetamol Treatment of the Borderline Significant PDA

Clinical trial NCT02819414 · UNKNOWN

Trial details

NCT number: NCT02819414
Sponsor: Shaare Zedek Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Patent Ductus Arteriosus

Start date: 2016-06-01
Primary completion: 2018-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.